KCNQ1 Protein (KV7.1)

KCNQ1 Protein (KV7.1)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KCNQ1 Protein (KV7.1)</th>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">cAMP/PKA</td>
<td>Phosphorylation (S27)</td>
</tr>
<tr>
<td class="label">PIP2</td>
<td>Membrane lipid binding</td>
</tr>
<tr>
<td class="label">Calmodulin</td>
<td>Ca²⁺ binding to C-terminus</td>
</tr>
<tr>
<td class="label">MAPK</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Oxidative Stress</td>
<td>Cysteine oxidation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/ovarian-cancer" style="color:#ef9a9a">Ovarian Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">149 edges</a></td>
</tr>
</table>

KCNQ1 Protein (KV7.1)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KCNQ1 Protein (KV7.1)</th>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">cAMP/PKA</td>
<td>Phosphorylation (S27)</td>
</tr>
<tr>
<td class="label">PIP2</td>
<td>Membrane lipid binding</td>
</tr>
<tr>
<td class="label">Calmodulin</td>
<td>Ca²⁺ binding to C-terminus</td>
</tr>
<tr>
<td class="label">MAPK</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Oxidative Stress</td>
<td>Cysteine oxidation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/ovarian-cancer" style="color:#ef9a9a">Ovarian Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">149 edges</a></td>
</tr>
</table>

KCNQ1 (also known as KV7.1 or KVLQT1) is a voltage-gated potassium channel encoded by the KCNQ1 gene on chromosome 11p15.5. It is the founding member of the KCNQ family of potassium channels (KCNQ1-5), which generate diverse neuronal and cardiac currents. KCNQ1 forms homomeric or heteromeric channels with KCNE accessory subunits, producing the slow delayed rectifier potassium current (I_Ks) in the heart and contributing to neuronal membrane repolarization in the brain.

KCNQ1 is critical for cardiac QT interval regulation, and mutations cause [long QT syndrome type 1 (LQT1)](https://pubmed.ncbi.nlm.nih.gov/9876472/) and [Jervell and Lange-Nielsen syndrome](https://pubmed.ncbi.nlm.nih.gov/9261978/). In the nervous system, KCNQ1 influences neuronal excitability and has been implicated in [epilepsy](/diseases/epilepsy), [Alzheimer's disease](/diseases/alzheimers-disease), and [Parkinson's disease](/diseases/parkinsons-disease).

Protein Structure

KCNQ1 has the canonical structure of voltage-gated potassium channels:

• N-terminal Domain (amino acids 1-100): Contains the A-domain (tetramerization domain) and parts of the voltage sensor
• Voltage Sensor Domain (VSD, amino acids 100-250): Six transmembrane segments (S1-S6) with S4 as the voltage sensor
• Pore Region (P-loop, amino acids 250-350): Between S5 and S6, contains the selectivity filter (GYG motif)
• C-terminal Domain (amino acids 350-676): Interaction sites for KCNE subunits, regulatory domains, and trafficking signals

Expression and Localization

KCNQ1 is expressed in multiple tissues:

• Heart: High expression in ventricular myocytes (atrial and ventricular)
• Brain: Moderate expression in various brain regions:
• [Cerebral cortex](/brain-regions/cortex) — layers 2/3 and 5
• [Hippocampus](/brain-regions/hippocampus) — CA1 region
• [Cerebellum](/brain-regions/cerebellum) — Purkinje cells
• [Basal ganglia](/brain-regions/basal-ganglia) — striatum
• Inner ear: Stria vascularis (collagen-like cells)
• Epithelia: Lung, kidney, intestine

Normal Function

Cardiac Electrophysiology

In the heart, KCNQ1 co-assembles with KCNE1 to form the I_Ks current:

• Repolarization: Contributes to phase 3 of the cardiac action potential
• Rate Adaptation: I_Ks increases with heart rate, shortening action potential
• QT Interval: KCNQ1/KCNE1 current determines QT duration

Neuronal Function

In neurons, KCNQ1:

• Membrane Repolarization: Contributes to M-currents in some neuronal populations
• Excitability Control: Regulates neuronal firing patterns
• Synaptic Integration: Modulates dendritic integration
• Homeostatic Regulation: Helps maintain ionic homeostasis

Epithelial Function

In epithelia, KCNQ1 regulates:

• Transepithelial chloride transport
• Fluid and electrolyte balance
• Ciliary beat frequency in airway epithelium

Role in Neurodegenerative Diseases

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease):

• Neuronal Excitability: Altered KCNQ1 expression may contribute to network hyperexcitability
• Aβ Effects: Amyloid-beta can modulate KCNQ1 channel function
• Calcium Regulation: KCNQ1 interacts with calcium signaling pathways
• Therapeutic Potential: KCNQ1 modulators may protect against Aβ toxicity

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease):

• Dopaminergic Neurons: KCNQ1 influences [dopaminergic neuron](/cell-types/dopaminergic-neurons) excitability
• Oxidative Stress: KCNQ1 function may be affected by oxidative stress
• Network Dysfunction: Altered KCNQ1 contributes to basal ganglia circuit abnormalities

Epilepsy

KCNQ1 mutations and variants are associated with:

• Febrile Seizures: KCNQ1 variants increase seizure susceptibility
• Temporal Lobe Epilepsy: Altered KCNQ1 expression in epileptic tissue
• Channelopathies: Mutations cause neuronal hyperexcitability

Stroke and Ischemia

KCNQ1 may play a role in:

• Ischemic neuron injury
• Post-stroke excitotoxicity
• Neuroprotection through modulation of excitability

Signaling Pathways

KCNQ1 is regulated by multiple signaling mechanisms:

Protein Interactions

KCNQ1 interacts with several proteins:

• KCNE1: Primary β-subunit in heart (I_Ks)
• KCNE2-5: Tissue-specific modulation
• Akt/PKB: Phosphorylation and regulation
• Yotiao: A-kinase anchoring protein
• Syntaxin 1A: Presynaptic regulation
• Hsp90: Chaperone for trafficking

Therapeutic Implications

Channel Modulators

• Retigabine (ezogabine): KV7.2-7.5 opener, approved for epilepsy (withdrawn for ophthalmologic toxicity)
• Flindlanderin B: KV7.1-4 activator
• XE-991: KV7.1-5 blocker
• Linopirdine: KV7.2-7.5 blocker

Drug Development

• Selective KCNQ1 activators: For cardiac applications
• Brain-penetrant KV7 modulators: For neurological applications
• Allosteric modulators: Targeting KCNE interaction sites

Clinical Applications

• Long QT Syndrome: β-blockers, pacing
• Atrial Fibrillation: KV7.1 modulators in development
• Epilepsy: KV7.2-7.4 activators (retigabine analogs)

Animal Models

• Kcnq1 Knockout Mice: Embryonic lethal (cardiac defects)
• Conditional Knockouts: Tissue-specific deletions
• LQT1 Mouse Models: Engineered human mutations
• Zebra fish: Developmental studies
• Drosophila: Neural function studies

Research Directions

Key research areas include:

References